Effectiveness of Ultrasound (US) Guided Supraclavicular Block

ClinicalTrials.gov ID: NCT00923494

Public ClinicalTrials.gov record NCT00923494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effectiveness of Ultrasound Guided Supraclavicular Brachial Plexus Block With 20, 30, or 40 ml of Ropivacaine 0.5%

Study identification

NCT ID: NCT00923494
Recruitment status: Withdrawn
Study type: Interventional
Phase: Not applicable
Lead sponsor: Baylor College of Medicine; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

20 ml of ropivacaine 0.5% Drug
30 ml of ropivacaine 0.5% Drug
40 ml of ropivacaine 0.5% Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 64 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 30, 2009
Primary completion: Nov 30, 2010
Completion: Nov 30, 2010
Last update posted: Jan 19, 2017

2009 – 2010

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Ben Taub General Hospital	Houston	Texas	77030	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00923494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 19, 2017 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00923494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →